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Short term sodium alendronate 
administration improves the peri-
implant bone quality in osteoporotic 
animals
Sodium alendronate is a bisphosphonate drug that exerts antiresorptive 
action and is used to treat osteoporosis. Objective: The aim of this study was to 
evaluate the bone repair process at the bone/implant interface of osteoporotic 
rats treated with sodium alendronate through the analysis of microtomography, 
real time polymerase chain reactions and immunohistochemistry (RUNX2 protein, 
?????????????????????????????????????????????????????????????????????????????
Material and Methods: A total of 42 rats were used and divided in to the following 
?????? ??????????????????????????????????????????????????????????????????????
and fed with a balanced diet), OST: osteoporosis group (rats submitted to a 
bilateral ovariectomy and fed with a low calcium diet) and ALE: alendronate 
group (rats submitted to a bilateral ovariectomy, fed with a low calcium diet 
and treated with sodium alendronate). A surface treated implant was installed 
in both tibial metaphyses of each rat. Euthanasia of the animals was conducted 
at 14 (immunhostochemistry) and 42 days (immunohistochemistry, micro CT 
????????????????????????????????????????????????????????????????????????????
level. Results: Bone volume (BV) and total pore volume were higher for ALE 
????????????????????????????????????????????????????????????????????????????
expressed in the ALE group (P<0.05), in comparison with the other groups. 
ALP expression was higher in the CTL group (P<0.05). The immunostaining for 
RUNX2 and osteopontin was positive in the osteoblastic lineage cells of neoformed 
???????????????????????????????????????????????????????????????????????????
phosphatase presented a lower staining area in the OST group compared to the 
CTL in both periods and the ALE at 42 days. Conclusion: There was a decrease 
of osteocalcin precipitation at 42 days for the ALE and OST groups. Therefore, 
treatment with short-term sodium alendronate improved bone repair around the 
implants installed in the tibia of osteoporotic rats.
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Introduction
Rehabilitation with dental implants has become 
widespread in society and most of the patients 
demanding this treatment are above 60 years old, a life 
stage in which osteoporosis is very common, especially 
in women7. Studies regarding dental implants in 
osteoporotic patients claim that the osteoporotic bone 
is similar to the proposed model of type IV bone, that 
is, residual bone formed by a thin layer of cortical 
bone surrounding the low density cancellous bone. 
????????????????????????? ????????????????????????????
quality, ranging from type I to IV13. Because of this, 
some authors contraindicate the use of implants in 
patients with osteoporosis, while others believe it is 
not a determining factor to contraindicate therapy with 
dental implants since the professional performs an 
??????????????????????????????????????????????????
larger diameter, implant surface treatment and a 
longer waiting period for prosthetic load application13,14.
 Regarding to the impact of osteoporosis on 
dental implant survival, Chen, et al.8 (2013) and 
Busenlechner, et al.5 (2014) reported that since there 
is no statistically significant differences between 
osteoporotic and non-osteoporotic patients that had 
been rehabilitated with dental implants, there is a 
strong correlation between this bone metabolism 
condition and implant survival, mainly in the 
mandible. These studies did not include a feasible 
number of patients to establish a comparison between 
osteoporotic and non-osteoporotic patients. Besides 
that, these clinical studies did not show indicate drugs 
used for osteoporosis.
Currently, several therapies are available for the 
treatment of osteoporosis, however, they present some 
????????? ???????? ??? ???????? ???? ?????????? ????????
The role of estrogen in bone integrity maintenance 
has been recognized for a while, although estrogen 
?????????????????????????????????????????????????????
including vascular events and breast carcinoma5. 
Some drugs act by decreasing bone resorption and 
therefore delaying bone loss rate (antiresorptive 
therapy), such as bisphosphonates, calcitonin and 
the human monoclonal antibody, denosumab, or by 
promoting bone formation (anabolic therapy), such as 
teriparatide1,3,14,18,19,28.
Sodium alendronate is part of the second generation 
of bisphosphonates, exhibiting less collateral effects in 
?????????????????????????????????????????????? ?????????
antiresorptive drug due to its low cost in comparison 
with other drugs17. The class of these drugs has a 
????? ???????? ???? ?????? ???????????? ???? ???????????
characteristics similar to pyrophosphate, that is, they 
are inhibitors of calcium hydroxyapatite crystal growth 
and exert their antiresorptive activity by inhibiting 
osteoclast development and migratory activity, and 
also by promoting their apoptosis4,31.
Several studies investigated the effects of the oral 
bisphosphonates in osteoporosis conditions related to 
?????????????????????1,4,6,14, bone mineral density3,6,9,20,28, 
bone strength3,28 and bone repair2,7,11,19. These studies 
still remain without some information regarding 
the molecular and microstructural features around 
implants in osteoporotic situations. For this reason, 
this study through immunolabeling, polimerase chain 
reactions, and microtomography analysis aimed to 
evaluate the bone repair process at the bone/implant 
interface of osteoporotic rats treated with sodium 
alendronate.
Material and methods
Experimental groups
This study followed the standards of the Ethics 
Committee on Animal Use (2012/0109-6) of the 
Brazilian College of Animal Experimentation - COBEA. 
Forty-two rats (Rattus norvegicus albinus, Wistar) of 
approximately 200 grams were divided in to three 
???????? ???? ?????? ?????????? ??? ?????????? ????????
and fed with a balanced diet containing 1.4% Ca, 
0.8% P and water ad libitum); OST (rats submitted 
to bilateral ovariectomies and fed with a low calcium 
diet containing 0.1% Ca, 0.5% P and water ad libitum, 
without medical treatment); and ALE (rats submitted 
to bilateral ovariectomies, fed with a low calcium diet 
and treated with sodium alendronate).
For the quantitative analysis (micro CT and PCR), 
after the Power Test calculation, the sample number 
for each group was a minimum of 6 (power test=0.8). 
Thus, as PCR was made in quadruplicate, we elected 
4 animals (left tibia) for this evaluation. For the micro 
CT evaluation, 6 animals were selected (4 right tibia 
belonging to the PCR groups plus 2 animals) with a 
total number of 18 animals.
For the qualitative analysis (immunhoistochemical), 
4 animals per group were selected for the periods (14 
and 42 days). Thus, we had obtained 24 animals. 
(N=42).
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Estrous cycle evaluation
The evaluation of the estrous cycle was performed 
according to the method described by Long and Evans16 
(1922), in which rats were separated into individual 
cages and their estrous cycles were assessed daily, 
for eight days.
Bilateral ovariectomy and low calcium diet 
(osteoporosis induction)
All rats were initially anesthetized with xylazine 
hydrochloride (Dopaser - Laboratório Calier do Brasil, 
????????????????????????????????????????????????????????
Dodge Animal Health Ltd, Campinas, SP, Brazil) to 
???????????????????????????????????????????????????
ovaries from the rats of the OST and ALE groups. 
From the CTL group, only the ovary exposure was 
performed.
The rats from the OST and ALE groups were fed 
with a low calcium diet (containing 0.1% Ca, 0.5% 
P and water ad libitum) and the CTL group was fed 
with a balanced diet containing 1.4% Ca, 0.8% P and 
water ad libitum.
The low calcium and phosphate diet was used 
in order to simulate a real osteoporosis situation. 
According to previous studies21,26,27, when rats were 
subjected to bilateral ovariectomies and fed with low 
calcium diet, there was a decrease of bone mineral 
density up to two higher greater. Thus, only those 
undergoing ovariectomy surgery could have an 
osteopenia condition. 
Sodium alendronate
Eight days after ovariectomy, the drug therapy 
???? ?????????? ??? ??????? ????? ??????? ???????? ???
sodium alendronate dissolved in an aqueous solution 
to the ALE group, as designed by Paz, et al.20 (2001), 
and gavage with saline solution to the OST and CTL 
groups. This treatment was conducted until the end 
of the experiment.
Implants
After fasting for eight hours, the animals were 
?????????????????????????? ???????????????????????
(Vetaset - Fort Dodge Animal Health Ltd, Campinas, SP, 
?????????????? ????????????????????????????????????????
- Laboratório Calier do Brasil, Ltd. - Osasco, SP, Brazil). 
???????????????????????????????????????????????????
scandicaine 2% with adrenaline 1:100,000, Septodont, 
Saint-Maur-des-Fossés, Paris, France) was used for 
analgesia and local vasoconstriction.
Then, the trichotomy was performed in the medial 
region of both tibias along with the antisepsis using 
Polyvinyl Pyrrolidone Iodine degermant (10% PVPI, 
Riodeine Degermant, Rioquímica, São José do Rio 
Preto, SP, Brazil) and a topical solution. An incision of 
approximately 3 cm was made with a divulsion of the 
soft tissue up to the tibial metaphyses exposure point.
In both tibias, a commercially available titanium 
implant with its surface treated by double acid etching 
was installed (Mater Pourus, Conexão Implant Systems 
Ltd., São Paulo, SP, Brazil). All implants were 1.6 mm 
in diameter and 3.0 mm in height. For milling, a spiral 
milling cutter with a diameter of 1.4 mm was used, 
mounted on an electric motor (BLM 600®; Driller, 
São Paulo, SP, Brazil) at a speed of 1000 rpm under 
irrigation with a 0.9% saline solution (Fisiológico®, 
Laboratories Biosintética Ltda®, Ribeirão Preto, SP, 
Brazil). The installation was manually conducted with 
??????????????
After placement of the implant, the suture 
was performed with absorbable wire (Polyglactin 
910 - Vycril 4.0, Ethicon, Johnson Prod, São José 
dos Campos, SP, Brazil) in the deep plan and with 
???????????? ????? ??????? ????? ????????? ?????????
Sao José dos Campos, SP, Brazil) on the external 
????????????????????????????????????????????????????
Dodge Animal Health Ltd, Campinas, SP, Brazil) in a 
single intramuscular dose as was Sodium Dipyrone 
??????????????????????????????????????????????????
Industries Ltd., São Paulo, SP, Brazil) in the immediate 
postoperative period.
In order to collect material, the animals were 
anesthetized following the anesthesia protocol for 
implant placement. Then, the implants of left tibias 
were removed by counter-torque and the bone 
material that was previously in contact with the 
implant was collected for RT-PCR analysis (real time 
polymerase chain reaction). At this moment, the rats 
were euthanized as outlined by Ramalho-Ferreira, et 
al.22 (2015) and the right tibias were removed and 
reduced with margins of about 1 cm to perform the 
Micro-CT analysis.
Microtomography evaluation (Micro-CT)
For the three-dimensional analysis of animals from 
the CTL, OST and ALE groups after euthanasia, at the 
42-day period, the right tibias that had been removed 
?????????? ??? ????????? ????????????????????? ???????
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??????????????? ??????????????????????????????????
????? ???????????????????????????????? ?????????????
computerized microtomography.
???? ??????? ????? ???????? ??? ?? ????????
????????????????? ????????? ????? ???????????????
Aatselaar, Belgium, 2003), using sections that were 
????????????????????????????????????????????????????
????????????????????????? ????????????????????????????
of 12.45 ???????????????????????? ????????????????
min. The images obtained by the projection of X-rays 
on the samples were stored and reconstituted to 
determine the area of interest by the NRecon software 
????????????????????????????????? ?????????????????????
correction of 8, beam hardening correction of 24% 
and the image conversion varied from 0.0 to 0.14. 
?????? ????????? ??????? ????????? ?????????? ????????
1.4.4, 64-bit), the images were reconstructed and 
observed in three planes (transversal, longitudinal 
and sagittal). Then, the CTAnalyser-CTAn software 
????????????????? ????? ?????????????? ????????
1.12.4.0) was used to determine bone volume, total 
volume of pore space and total porosity (percent), 
?????????????????????????????????????????????????????
??????????????????????????????????????
RT-PCR
After removing the left tibial implants, the bone 
around the peri-implant defect was removed with a 
Carborundum disc mounted on a straight handpiece 
and micromotor. Pieces for molecular analysis were 
processed to perform the experiments in RT-PCR 
StepOne Plus, in order to evaluate the expression of 
the gene encoding proteins related to bone repair.
To execute the experiment, each bone fragment 
removed after material collection was carefully 
washed in a phosphate buffered saline solution (PBS), 
frozen in liquid nitrogen and stored at -80°C in a 
freezer for total RNA extraction with Trizol reagent 
(Life Technologies Invitrogen, Carslbad, CA, USA) 
?????????????????????????????????????????????????????
(Promega, Madison, Wisconsin, USA) according to the 
??????????????? ??????????????? ?????? ??????????? ??????
?????????????????????????????????????????????????????
of concentrations and purity were performed using a 
spectrophotometer, and the integrity was analyzed by 
use of a denaturing agarose gel.
Following these analyzes, the normalization of total 
RNA concentration of each sample was performed with 
ultrapure water (Sigma-Aldrich, St. Louis, Missouri, 
USA) for the manufacturing of cDNA strands by 
the reverse transcriptase reaction, using the High 
????????? ????? ???????? ?????????????? ???? ?????????
Biosystems, Foster City, California, USA). The RT-PCR 
?????????????????????????????????????????????????????
expression related to bone repair were made using 
SybrGreen system (Applied Biosystems, Foster City, 
California, USA) in the StepOne Plus device (Applied 
Biosystems, Foster City, California, USA). The reactions 
were performed in quadruplicate, Taqman Universal 
PCR Master Mix was added to plates containing the 
genes of interest and cDNA volumes were calculated 
?????????????????????????????????????????????
????????????????????????????????????????????????
for 2 minutes, 95°C for 10 minutes, with 40 cycles at 
95°C for 15 seconds and then at 60°C for 1 minute 
(denaturation and extension). The results were 
analyzed based on the Ct value (cycle threshold), that 
is the point corresponding to the number of cycles 
??????????????????????????????????????????????????
????????????????????????????????????????????????????
controls and the phase of the samples exponential 
??????????????? ?????? ???????? ???? ???? ?????????????
analysis of the interested genes expression and the 
ones related on the plate. As an endogenous control, 
the expression of beta-actin constitutive gene was 
evaluated, which is used for the normalization of 
expression levels of the genes evaluated (RUNX2, 
???????????????????????????????????????????
Immunohistochemistry
???????????????????????????????????????????????
??????????????????????????????????????????????????
dehydration was carried out using a sequence of 
alcohols. The diaphanization was performed with 
????????????????????????????????????????????????????????
????? ???????????? ??? ?? ???? ???? ????????????? ???
slides. The immunohistochemical reactions were 
used to characterize the osteoblastic phenotype 
from the presence of proteins that featured different 
stages of osteoblast maturation, starting with the 
transcription factor RUNX2 (pre-osteoblast cells); 
????????? ????????????? ???????? ???? ?????????? ???
mineralization process by phosphate ion precipitation; 
????????????? ??????????????????? ???????????? ????
the beginning of bone mineralization activity; and 
Osteocalcin, which is a late protein, considered to be 
????????????????????????????????????????????????????
last stage of osteoblast maturation. These proteins 
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were analyzed in periods of 14 and 42 days.
This process was obtained by inhibiting the activity 
of endogenous peroxidase with hydrogen peroxide, 
?????? ??? ???? ??????????? ???????? ??????? ?????????
phosphatase, osteopontin and osteocalcin. These 
antibodies are polyclonal and are produced in goats 
(Santa Cruz Biotechnology, Paulinia, SP, Brazil).
Immunohistochemical experiments were performed 
using immunoperoxidase as detection medium. The 
antibody used was the secondary biotiniladoanti-goat 
produced in rabbits (Pierce Biotechnology, São Paulo, 
??????????????????????????????????????????????????????
?????????????????????????????????????????????????
??????????????????????????? ????????????????????????
The proteins expression was analyzed in the region 
of the implant threads, by assigning scores: 1 
representing light staining, 2 moderate and 3 severe. 
These scores were established according to the study 
performed by Ramalho-Ferreira, et al.21 (2016), in 
which light staining represented about 25% of the 
immunolabeling area in the blades; moderate staining 
represented about 50% of the immunolabeling area 
in the blades; and severe staining represented about 
75% of the immunolabeling area in the blades.
Statistical analysis
For statistical analysis, the software Sigmaplot 
12.3 (Systat Software, Inc. SigmaPlot for Windows, 
San Jose, CA, USA) was used. The homoscedasticity 
?????????????????????????????????????????????????????
to distinguish the parametric and nonparametric data. 
For analysis of the PCR parametric data, the total pore 
volume and the percentage of total porosity (micro-
?????????????????????????????????????????????????
performed. For bone volume heterogeneous data 
?????????????????????????????????????????????????????
?????????????????????????????????????????????????????
p<0.05.
Results
Micro-Ct
The pieces’ scans were made in the CTL, OST 
and ALE groups, 42 days after implant placement. 
Quantitatively, the median bone volume obtained in 
the CTL group was 0.0256 mm³, in the OST group it 
was 0.0276 mm³, with a considerable increase in the 
ALE group, showing 0.0497 mm³.
Based on the results for bone volume, there 
were statistical differences between the 3 groups 
?????????? ????????????????? ??????????? ?? ???????????
when comparing the CTL with the ALE group, with 
p<0.05 (Dunn’s post-test) (Figure 1A).
The averages of total pore volume in peri-implant 
bone tissue obtained for the CTL, OST and ALE groups 
were respectively 0.387, 0.361 and 0.338, in which 
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????? ???? ???? ??????? ??????? ???????????? ????????????
??? ????????? ??? ???? ??????? ????????? ?????? ???????
Regarding the percentage of total porosity, the values 
were 94.189 (CTL), 92.924 (OST) and 87.596 (ALE) 
?????????????????????????????????????????
PCR
The osteoblastic differentiation protein RUNX2 
????????????????????????????????????????????????????
followed by the CTL (1.39) and the OST (0.21) 
????????????? ????????????????????
Considering the ALP, the highest values were 
observed in the CTL (1.01), followed by the ALE (0.84), 
and the lowest values were exhibited by the OST group 
????????????????????????????????????????
??????????????????????????????????????? ??? ????
ALE group (3.03), followed by the CTL (1.43) and OST 
???????????????????????????? ????????????????????
Concerning the osteocalcin, only the comparison 
between the ALE (6.43) and the OST (0.13) presented 
????????????????????????????????????????????????????????
tendency of higher values for the ALE group in relation 
to the other groups studied, including the CTL (1.00) 
(Figure 2D).
Immunohistochemical analysis
Immunohistochemical analysis performed at 14 
and 42 days can be observed by the staining scores 
(Figure 3).
For RUNX 2, light to moderate staining was 
observed in the CTL group, light staining in the OST and 
moderate in the ALE at 14 days of osseointegration. 
After 42 days, immunostaining showed a light presence 
of RUNX2 in the three experimental groups (Figure 4).
???? ????????? ???????????? ??????? ?????????
expression in the CTL group at 14 and 42 days. Its 
reduction in the osteoporotic model (OST) is presented 
at 14 and 42 days, with light immunostaining. The 
administration of sodium alendronate in osteoporotic 
animals showed a moderate score at 14 days, with a 
reduction at 42 days (Figure 5).
The staining observed for osteopontin was 
moderate in the CTL, OST and ALE groups at 14 days 
of osseointegration. This moderate immunostaining 
was maintained at 42 days for both the CTL and OST 
groups, but became light in the ALE group (Figure 6).
Regarding osteocalcin labeling, moderate 
 CTL 14 2 2 2 2
 CTL 42 1 2 2 2
OST 14 1 1 2 1
OST 42 1 1 2 1
 ALE 14 2 2 2 2
 ALE 42 1 1 1 1
Figure 3- Scores observed in the marking of RUNX2, OP, OC 
and ALP proteins, in the different experimental groups
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Figure 4-????????? ?????????????????????????????????????? ??????????????????? ????????????????????? ???? ?????????? ????????????????
???????????????????????????????????????????????????????????????????????????????????????
Figure 5-?????? ?????????????????????????????????????? ??????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
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Figure 6-? ??? ?????????????????????????????????????? ??????????????????? ????????? ???? ????????? ???? ?????????? ????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
Figure 7-????? ???????????????????????????? ?????????? ?????????????????????????????????? ????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
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immunostaining was observed in the CTL group at 
14 and 42 days, and in the OST and ALE groups, 
staining was moderate at 14 days, with mineral 
decrease indicated by a light immunostaining at 42 
days (Figure 7).
Discussion
The results of the current study were consistent 
to accept the hypothesis designed by the authors 
that the treatment with sodium alendronate in rats 
with induced osteoporosis would improve bone repair 
around the implants installed in the tibia. Through 
microtomographic (BV and Po.V) and molecular 
parameters (relative expression of RUNX2 and BSP) 
and through the proteins RUNX2 and OPN, it became 
evident that the rats from the ALE group exhibited 
superiority in repair standards for achieving greater 
bone volume and simultaneously a greater maturation 
in comparison to the control groups (CTL and OST). 
Except in phosphate precipitation in which the CTL 
was higher than the other groups.
A crucial factor for implant stability, especially in 
the early stages of the bone repair process, is the 
quality of tissue that will support the osseointegrated 
implant29. In this context, osteoporosis decreases bone 
mass in long bones and the maxillofacial complex, as 
demonstrated by clinical studies15. Considering that 
maxillary bones present decreased density due to the 
structural characteristics of their micro-architecture, 
mainly in the posterior regions, the presence of 
osteoporosis decreases the implants stability during 
installation and, therefore, increases the failure rate9,25.
Therefore, osteoporosis therapy consists of 
increasing bone mineral density in order to reduce long 
bone and vertebrae fractures. Thus, anti-resorptive 
medications, such as sodium alendronate, have 
been effective in this treatment1,4,7,14,20. Apparently, 
according to previous studies7,11,12,19,28, sodium 
alendronate is also able to improve bone repair at the 
bone/implant interface under osteoporosis conditions, 
at least at the beginning of the bone tissue evaluation.
??????????????????????????????????????????????????
resorptive potential of ALE in lower quality bones. 
Considering the molecular and immunohistochemical 
results, the staining observed for RUNX2 showed 
lightly to moderately expressed pre-osteoblasts at 
14 days in the OST group, presenting an increase 
in transcription factor expression, perhaps in an 
attempt to recruit a greater number of osteoblasts, 
offsetting the decrease in osteoblast activity due to the 
osteoporosis installed on this experimental group. The 
ALE group showed similar results to the CTL group, 
????????? ???????????????????????????????????????????
the beginning of mineralization, and light staining at 42 
?????????????????????????????????????????????????????
and showing a positive action of the administered 
medication. When quantifying this protein by real time 
PCR at 42 days, the highest values were found for 
the ALE group, even greater than the positive control 
group (CTL) (P<0.001), which demonstrated the 
highest signaling of osteoblast recruitment for bone 
tissue formation in this experimental group.
????? ?????????????????????????????????? ?????????
bone mineralization, showed differences in the quality 
of bone tissue formed during the repair process. 
The CTL group showed the highest expression of 
this protein, while the osteoporosis group presented 
the lowest expression. At 14 days, the presence of 
osteocalcin was similar in the ALE (moderate staining) 
when compared to the CTL group (moderate staining). 
However, at 42 days, it remained moderate in the CTL 
group and became light in the OST and ALE groups.
At 14 days, the bone lining cells were observed to 
have positive staining for this protein, especially in 
the CTL group. The moderate presence of osteocalcin 
in the CTL group at 42 days characterizes mature 
bones and a mineralization activity, which may be 
related to a satisfactory osseointegration process, 
featuring bone tissues that can offer adequate support 
for implant installation. However, at 42 days, the 
osteoporotic animals treated with alendronate showed 
slight staining for osteocalcin, characterizing a lower 
mineralization of the bone formed along the implants. 
?????????????? ??????????????? ???? ??????????????????
since even with a trend of increased gene expression 
for osteocalcin in relation to the other groups, there 
???? ??? ?????????????? ??????????? ??????????? ??????????
Hence, in the long term, ALE will probably present 
reduction in bone tissue maturation.
Whilst considering bone tissue maturation 
??????????????????????????????????????????????????????
osteoporosis seems to be consistent with a decrease 
????????????????????????????????????????????????????????
phosphatase is an enzyme which acts at the beginning 
of the phosphate precipitation process over the collagen 
matrix of bone tissue31. It is also considered to be a 
????????????????????????????????????????????10. Studies 
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have shown that the use of sodium alendronate, in 
the long term, can lead to alterations in this protein’s 
activity24. This drug has structural characteristics 
similar to pyrophosphate, inhibiting the growth of 
calcium hydroxyapatite crystals, with the increase 
in pyrophosphate being related to decreased 
mineralization. Because of this correlation, the 
? ????????????????????????????????????? ???? ????????
during the osseointegration periods in this study.
????? ????????? ????? ????????? ???????????? ????
???????????????????? ???????? ?????? ??????????????
to detect and follow the course of hepatobiliary 
???? ????????? ??????????????31 (1994) related that 
molecular studies of hypophosphatasia, a rare 
?????????? ???????? ????????? ????? ????????? ???? ?????
???????????????????????????????????????????????????????
??????????????? ??? ???????? ?????? ????????? ??????? ???
bone repair such as those used in this study (ALP, BSP, 
osteopontin and ostecalcin) through molecular and 
immunohistochemical reactions are very important 
in understanding the aspects involved with bone 
formation at different phases (osteoblasts induction 
and bone maturation).
Osteoblasts presented positive staining for 
osteopontin especially in regions close to implant 
spirals, showing activity of bone remodeling close to 
the osseointegration areas. Staining for osteopontin 
was moderate in the CTL, OST and ALE groups at 14 
days of osseointegration due to the intense cellular 
activity in this period. This moderate immunostaining 
remained at 42 days for both the CTL and OST 
groups, but became light in the ALE group. It is worth 
noting the presence of bone lining cells, positive for 
osteopontin in the CTL group at 14 days, showing the 
formation of the osteopontin interfaces.
Tomographic parameters are essential for the 
correct planning of the clinical atrophy diagnosis of a 
bone that will receive implants, because of the cortical/
medullary characteristics observed in more accurate 
imaging exams, which will influence the choice 
of the implants macrogeometry, the best surface 
treatment technique and the most indicated prosthetic 
connection2,11. The microtomography performed on 
the pieces of this study was directly related to the 
increase in bone volume to ALE, even in comparison 
with CTL (p=0.012), at the same time in which the 
characteristics related to density, the ALE group 
presented smaller pore volumes than the other groups 
(CTL and OST; p>0.05). These characteristics indicate 
that treatment with ALE promoted higher volumes 
of available bone and higher densities, fundamental 
factors for the stability of rehabilitation treatment.
Even though these results are encouraging for 
the primary indication of alendronate under these 
osteoporotic conditions, especially regarding the best 
structural bone characteristics, an evident concern 
is about maintaining these characteristics over 
time. The molecular and immunohistochemical data 
????????? ?????????? ???????????????????????????????
and, consequently, a cellular characteristic that is 
unfavorable to the process of bone tissue formation 
in treatments with alendronate. These results suggest 
that in the long term, there is a detriment in the 
quality of bone formed during the osseointegration 
process, which seems to be correlated with the 
reduced production of the proteins that favor bone 
tissue formation.
In addition to these probable limitations, the 
literature also describes the possibility of this 
treatment to cause maxillary osteonecrosis23. Even 
though alendronate is an oral bisphosphonate that 
is less powerful when compared to other intravenous 
?????????????? ???? ???? ??? ?????? ???????? ??????? ???
osteonecrosis induction, both in tooth extraction 
surgery and in loss of dental implants that have been, 
sometimes, installed for decades17,31.
This study was statically conducted on peri-implant 
?????????????????????????????????????????????????????
is related to dynamic changes in the bone, mainly due 
to physiological changes observed during mastication 
loads on implant-supported prostheses. Given the 
statements above, new studies must be designed, 
with a primary transcutaneous load application on the 
implants after bone tissue maturation (42 days), with 
micromotion devices, as described by Wazen30 (2013).
As previously emphasized, another issue to be 
investigated concerns the question: what is  the 
behavior of osteoporotic bone treated with ALE in the 
long term? Thus, future research should examine the 
same conditions of this study, but at 6 month and 
1 year periods after implant placement, to mimic 
rehabilitation after 24 and 48 months, corresponding 
to humans.
Based on the information described above and on 
the limits of this in vivo study, it was concluded that 
short-term treatment with sodium alendronate in 
rats with induced osteoporosis improved bone repair 
around the implants installed in the tibia. Otherwise, 
Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals
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more studies are necessary in order to evaluate the 
quality of the peri-implant bone under long-term 
sodium alendronate administration in the presence of 
the osteoporotic condition.
????????????????
???????????? ???????????????????????????????????????
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